Executive Profile

Geoffrey M. Duyk M.D., Ph.D. Board Observer, Alphabet Energy, Inc.

Age	Total Calculated Compensation	This person is connected to 12 Board Members in 12 different organizations across 19 different industries. See Board Relationships
53	--

Background

Dr. Geoffrey M. Duyk, Geoff, M.D., Ph.D. is Partner of TPG Biotech and serves as it's Managing Director. Dr. Duyk serves as Managing Director of TPG Growth. Dr. Duyk served as President of Research & Development at Exelixis Inc. from January 2003 to December 2003. Dr. Duyk served as Exelixis Inc.'s Executive Vice President and Chief Scientific Officer from April 1997 to December 2002. Previously, Dr. Duyk was one of the founding scientific staff at Millennium Pharmaceuticals ... Inc. (now Millennium: The Takeda Oncology Company) and served as Vice President of Genomics at Millennium Pharmaceuticals Inc. Dr. Duyk serves as the Chairman of EPIRUS Biopharmaceuticals, Inc., moksha8 Pharmaceuticals, Inc. and Elevance Renewable Sciences, Inc. He served as the the Chairman at Aerie Pharmaceuticals, Inc. He serves as a Member of The Scientific Advisory Board at VLST Corporation. He serves as a Director of at Aerie Pharmaceuticals, Inc., Avidia Research Institute (a/k/a Avidia, Inc.), Open Biosystems, Inc., Galleon Pharmaceuticals, Inc., DNAnexus, Inc., Karos Pharmaceuticals, Inc. and FoldRx Pharmaceuticals, Inc. He has been a Director at Amyris, Inc. since May 2012, and Elevance Renewable Sciences, Inc. since November 2007. He has been Board Observer of Alphabet Energy, Inc. since September 15, 2011. He serves as a Board Observer of Ultragenyx Pharmaceutical Inc. He served as a Director of Signature Bioscience, Inc., ShangPharma Corporation, Guava Technologies, Inc., Exelixis Inc. since April 1998 and MacroGenics, Inc. since October 15, 2004. He served as a Director of Replidyne, Inc. since June 2004, Agria Corporation from August 2007 to May 2009 and Amyris, Inc. from May 2006 to April 2011. He was an Assistant Professor at Harvard Medical School and Assistant Investigator of the Howard Hughes Medical Institute from 1992 to 1994. He serves as a member of the Board of Directors of the American Society of Human Genetics. While at Harvard Medical School, he was a co-Principal Investigator in the NIH-funded Cooperative Human Linkage Center. Dr. Duyk holds a B.A. in Biology from Wesleyan University in 1980 and a Ph.D. and M.D. from Case Western Reserve University and completed his residency and post-doctoral training in Medical Science at University of California, San Francisco. He was also awarded a post-doctoral fellowship from the Howard Hughes Medical Institute.

Corporate Headquarters 239 8th street San Francisco, California 94103 United States Phone: 415-555-1234 Fax: -- Board Members Memberships Former President of Research & Development and Director Exelixis, Inc. Former Director Guava Technologies, Inc. Director Signature Bioscience, Inc. Former Director MacroGenics, Inc. Director Open Biosystems, Inc. Director Avidia, Inc. Director FoldRx Pharmaceuticals, Inc. Director Galleon Pharmaceuticals, Inc. Director Aerie Pharmaceuticals, Inc. Former Director ShangPharma Corporation Chairman of the Board moksha8 Pharmaceuticals, Inc. Director DNAnexus, Inc. Member of the Board of Directors Karos Pharmaceuticals, Inc. Chairman EPIRUS Biopharmaceuticals, Inc. 2004-N/A Former Director, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee Replidyne, Inc. 2007-2009 Former Director Agria Corporation 2007-Present Chairperson Elevance Renewable Sciences, Inc. 2012-Present Director and Member of Audit Committee Amyris, Inc. Education PhD Case Western Reserve University MD Case Western Reserve University Post-Doctoral Training University of California-San Francisco BA 1980 Wesleyan University Post-Doctoral Training Howard Hughes Medical Institute in Dallas Other Affiliations Exelixis, Inc. Millennium Pharmaceuticals, Inc. Guava Technologies, Inc. Signature Bioscience, Inc. MacroGenics, Inc. TPG Growth Replidyne, Inc. Case Western Reserve University University of California-San Francisco Wesleyan University Open Biosystems, Inc. VLST Corporation Avidia, Inc. FoldRx Pharmaceuticals, Inc. Galleon Pharmaceuticals, Inc. Aerie Pharmaceuticals, Inc. Amyris, Inc. Agria Corporation Howard Hughes Medical Institute in Dallas ShangPharma Corporation moksha8 Pharmaceuticals, Inc. Elevance Renewable Sciences, Inc. TPG Biotechnology Partners III, L.P. DNAnexus, Inc. Karos Pharmaceuticals, Inc. TPG Biotech Ultragenyx Pharmaceutical Inc. EPIRUS Biopharmaceuticals, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.